As ICER places a spotlight on pharma's price hikes, J&J, Roche and more hit back

[cafead]

via After many years of tracking the pharmaceutical industry’s pricing tactics, the Institute for Clinical and Economic Review (ICER) is once again placing a spotlight on the price increases that end up costing the U.S. healthcare system the most.

article source